Accelr8 Announces Reduced Losses While Focusing on Rapid MRSA Identification in Hospital Acquired Infections

Accelr8 Technology Corporation (Amex:AXK) reported a loss of $456,359 or $0.05 per share on net revenues of $85,149 for the quarter ended January 31, 2007. In the comparable three-month period of fiscal 2006, Accelr8 reported a net loss of $785,545 or $0.08 per share on net revenues of $55,490.

Source: Accelr8